Specialist in pharmaceutical sciences with a strong focus on the design and development of innovative therapeutics aimed at correcting molecular and cellular dysfunctions underlying cardiovascular diseases. My research integrates cutting-edge methodologies in molecular biology, cellular pharmacology, and nanotechnology, allowing for the rational design of highly selective and efficacious drug candidates with minimized off-target effects. By bridging fundamental science with translational applications, I strive to advance precision medicine approaches that offer both improved patient outcomes and enhanced safety profiles.